1.浠水县人民医院胃肠外科 湖北 黄冈 438299
2.武汉大学中南医院甲状腺乳腺外科 湖北 武汉 430071
李栋梁,男,1976—,副主任医师,主要从事恶性肿瘤的发病机制研究, E‑mail:lichenglidongliang@163.com
刘九洋,男,1990—,医学博士,主治医师,主要从事恶性肿瘤侵袭转移的分子机制研究, E‑mail:ahljywhu204@163.com
收稿:2023-07-03,
纸质出版:2025-03-25
移动端阅览
李栋梁,刘九洋.甲状腺微小乳头状癌侧颈区淋巴结转移危险因素分析——附2例病例报告[J].武汉大学学报(医学版),2025,46(03):343-349.
LI Dongliang,LIU Jiuyang.Risk factors of lateral lymph node metastasis in papillary thyroid carcinoma with two case reports[J].Medical Journal of Wuhan University,2025,46(03):343-349.
李栋梁,刘九洋.甲状腺微小乳头状癌侧颈区淋巴结转移危险因素分析——附2例病例报告[J].武汉大学学报(医学版),2025,46(03):343-349. DOI: 10.14188/j.1671-8852.2023.0374.
LI Dongliang,LIU Jiuyang.Risk factors of lateral lymph node metastasis in papillary thyroid carcinoma with two case reports[J].Medical Journal of Wuhan University,2025,46(03):343-349. DOI: 10.14188/j.1671-8852.2023.0374.
甲状腺乳头状癌发病率逐年升高,其中甲状腺微小乳头状癌占比约50%左右。但是因为甲状腺微小乳头状癌进展慢、预后较好,人们往往忽略了其属于恶性肿瘤的本质。我们在长期的临床实践中发现部分“小肿瘤,大转移”的病例,其发生率为1%~11.2%,相对少见,且早期易漏诊,部分以颈部淋巴结肿大为主要症状就诊。因此,探究甲状腺微小乳头状癌侧颈区转移的风险因素对临床医生判断淋巴结清扫范围、降低患者复发率具有重要意义。一般而言,侧颈部淋巴结转移的风险因素主要包括:性别、年龄、肿瘤大小、肿瘤位置、多灶性、腺外侵袭、组织学亚型、基因突变、中央区淋巴结转移。本文主要通过文献复习,并结合两例甲状腺微小乳头状癌伴颈部淋巴结转移的典型病例,分析潜在风险因素,以提高对此类疾病认识。
The incidence of papillary thyroid cancer is increasing year by year
with thyroid micropapillary carcinoma accounting for about 50%. Because papillary thyroid carcinoma progresses slowly and has a better prognosis
its malignant nature is often overlooked. Some cases of "tiny tumor and large metastasis" which occur at a rate of 1% to 11.2%
are relatively rare and easily missed in clinical practice. These cases may also present with palpable lateral lymphadenopathy. Therefore
it is important to explore the risk factors of lateral lymph node metastasis in papillary thyroid carcinoma for clinicians to determine the extent of lymph node dissection and reduce the recurrence rate. Generally
risk factors for lateral lymph node metastasis include gender
age
tumor size
tumor location
multifocality
extrathyroidal extension
histological subtypes
genetic mutations
and central lymph node metastases. In this article
we analyzed potential risk factors to improve understanding of papillary thyroid carcinoma with lateral lymph node metastasis through a literature review and in combination with two typical cases of this disease.
HAUGEN B R , ALEXANDER E K , BIBLE K C , et al . 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer [J ] . Thyroid , 2016 , 26 ( 1 ): 1 ‑ 133 .
ZHANG L , WEI W J , JI Q H , et al . Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: A study of 1 066 patients [J ] . J Clin Endocrinol Metab , 2012 , 97 ( 4 ): 1250 ‑ 1257 .
郑克思 , 曾勇 , 陈聪 , 等 . 基于监测、流行病学和最终结果数据库甲状腺乳头状微癌颈部淋巴结转移的危险因素 [J ] . 中国医学科学院学报 , 2018 , 40 ( 6 ): 736 ‑ 743 .
ZHENG K S , ZENG Y , CHEN C , et al . Risk factors of cervical lymph node metastasis in papillary thyroid microcarcinoma: An analysis based on data from the surveillance, epidemiology and end results database [J ] . Acta Acad Med Sin , 2018 , 40 ( 6 ): 736 ‑ 743 .
杨绍时 , 周扬 , 柴慈曼 , 等 . 甲状腺微小乳头状癌组织学亚型的临床病理意义及与颈部淋巴结转移的关系 [J ] . 天津医药 , 2022 , 50 ( 6 ): 638 ‑ 642 .
YANG S S , ZHOU Y , CHAI C M , et al . Clinicopathological significance of histological subtypes in papillary thyroid microcarcinoma and its correlation with cervical lymph node metastasis [J ] . Tianjin Med J , 2022 , 50 ( 6 ): 638 ‑ 642 .
BACK K , KIM J S , KIM J H , et al . Superior located papillary thyroid microcarcinoma is a risk factor for lateral lymph node metastasis [J ] . Ann Surg Oncol , 2019 , 26 ( 12 ): 3992 ‑ 4001 .
LUO Y , ZHAO Y , CHEN K , et al . Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma [J ] . J Endocrinol Investig , 2019 , 42 ( 2 ): 227 ‑ 236 .
WENG H Y , YAN T , QIU W W , et al . The prognosis of skip metastasis in papillary thyroid microcarcinoma is better than that of continuous metastasis [J ] . J Clin Endocrinol Metab , 2022 , 107 ( 6 ): 1589 ‑ 1598 .
WU X , LI B , ZHENG C , et al . Predicting factors of lateral neck lymph node metastases in patients with papillary thyroid microcarcinoma [J ] . Medicine (Baltimore) , 2019 , 98 ( 27 ): e16386 .
XU Y N , XU L , WANG J D . Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: Analysis of 3607 patients at a single institution [J ] . J Surg Res , 2018 , 221 : 128 ‑ 134 .
PAPACHRISTOS A , DO K , TSANG V H , et al . Outcomes of papillary thyroid microcarcinoma presenting with palpable lateral lymphadenopathy [J ] . Thyroid , 2022 , 32 ( 9 ): 1086 ‑ 1093 .
PERRIER N D , BRIERLEY J D , TUTTLE R M . Differentiated and anaplastic thyroid carcinoma: Major changes in the American joint committee on cancer eighth edition cancer staging manual [J ] . CA Cancer J Clin , 2018 , 68 ( 1 ): 55 ‑ 63 .
尹艺蓉 , 王秀秀 , 余霄龙 , 等 . 甲状腺乳头状微小癌颈部淋巴结转移的影响因素分析 [J ] . 现代肿瘤医学 , 2022 , 30 ( 2 ): 223 ‑ 227 .
YIN Y R , WANG X X , YU X L , et al . Analysis of influencing factors of cervical lymph node metastasis in thyroid papillary mi‑crocarcinoma [J ] . J Mod Oncol , 2022 , 30 ( 2 ): 223 ‑ 227 .
KALISZEWSKI K , DIAKOWSKA D , WOJTCZAK B , et al . Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"? [J ] . World J Surg Oncol , 2019 , 17 ( 1 ): 91 .
XU D , LV X , WANG S , et al . Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma [J ] . Int J Clin Exp Pathol , 2014 , 7 ( 9 ): 6199 ‑ 6205 .
ZHANG X , ZHANG L , XUE S , et al . Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension [J ] . Asian J Surg , 2019 , 42 ( 4 ): 563 ‑ 570 .
高明 , 葛明华 , 嵇庆海 , 等 . 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版) [J ] . 中国肿瘤临床 , 2016 , 43 ( 10 ): 405 ‑ 411 .
GAO M , GE M H , JI Q H , et al . China expert consensus on diagnosis and treatment of thyroid micropapillary carcinoma (2016 edition) [J ] . Chin J Clin Oncol , 2016 , 43 ( 10 ): 405 ‑ 411 .
ZHAO L , SUN X Y , LUO Y K , et al . Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas [J ] . Ann Diagn Pathol , 2020 , 49 : 151647 .
中华人民共和国国家卫生健康委员会 . 甲状腺癌诊疗规范(2018年版) [J ] . 中华普通外科学文献 (电子版), 2019 , 13 ( 1 ): 1 ‑ 15 .
National Health Commission of the People's Republic of China . Diagnosis and treatment guidelines for thyroid cancer(2018 edition) [J ] . Chin Arch Gen Surg Electron Ed , 2019 , 13 ( 1 ): 1 ‑ 15 .
吴昊 , 段海明 , 刘金生 . AEG‑1和SKA3在甲状腺微小乳头状癌组织中的表达及临床意义 [J ] . 临床肿瘤学杂志 , 2022 , 27 ( 7 ): 577 ‑ 582 .
WU H , DUAN H M , LIU J S . Expression of AEG‑1 and SKA3 in thyroid papillary carcinoma tissues and its clinical significance [J ] . Chin Clin Oncol , 2022 , 27 ( 7 ): 577 ‑ 582 .
薛栋 , 王平安 , 宋德坤 . 甲状腺乳头状癌中PDK1、ZEB1和Vimentin的表达及其临床意义 [J ] . 中国现代普通外科进展 , 2021 , 24 ( 2 ): 89 ‑ 92 .
XUE D , WANG P A , SONG D K . Expressions and clinical signifances of PDK1, ZEB1 and Vimentin in papillary thyroid carcinoma [J ] . Chin J Curr Adv Gen Surg , 2021 , 24 ( 2 ): 89 ‑ 92 .
王雨竹 , 彭梅 , 姜凡 , 等 . 超声联合BRAF V600E基因检测模型在主动监测甲状腺微小癌侵袭性中的应用 [J ] . 安徽医科大学学报 , 2022 , 57 ( 4 ): 640 ‑ 644 .
WANG Y Z , PENG M , JIANG F , et al . Application of ultrasound combined with BRAF V600 E gene detection model in proactively detecting the aggressiveness of thyroid microcarcinoma [J ] . Acta Univ Med Anhui , 2022 , 57 ( 4 ): 640 ‑ 644 .
刘威 , 彭梅 , 姜凡 , 等 . 超声检查联合基因及血清检测预测甲状腺微小乳头状癌的侵袭性 [J ] . 中国超声医学杂志 , 2020 , 36 ( 12 ): 1071 ‑ 1074 .
LIU W , PENG M , JIANG F , et al . Application of ultrasound examination combined with BRAF V600E gene and serum TSH in predicting PTMC aggressiveness [J ] . Chin J Ultrasound Med , 2020 , 36 ( 12 ): 1071 ‑ 1074 .
ALIYEV E , LADRA‑GONZÁLEZ M J , SÁNCHEZ‑ARES M , et al . Thyroid papillary microtumor: Validation of the (updated) Porto proposal assessing sex hormone receptor expression and mutational BRAF gene status [J ] . Am J Surg Pathol , 2020 , 44 ( 9 ): 1161 ‑ 1172 .
PARVATHAREDDY S K , SIRAJ A K , IQBAL K , et al . TERT promoter mutations are an independent predictor of distant metastasis in middle eastern papillary thyroid microcarcinoma [J ] . Front Endocrinol (Lausanne) , 2022 , 13 : 808298 .
KUCHARECZKO A , KOPCZYŃSKI J , KOWALIK A , et al . A significance of concomitant BRAF V600E and TERT mutations in Polish patients with papillary thyroid microcarcinoma: A retrospective cohort study based on 430 cases [J ] . Thyroid , 2022 , 32 ( 11 ): 1372 ‑ 1381 .
李新发 . 多层螺旋CT在甲状腺微小乳头状癌诊断中的应用价值 [J ] . 医疗装备 , 2022 , 35 ( 10 ): 25 ‑ 27 .
LI X F . Application value of multi‑slice spiral CT in diagnosis of papillary thyroid carcinoma [J ] . Med Equip , 2022 , 35 ( 10 ): 25 ‑ 27 .
李皓盈 , 王海燕 , 翁璐昕 . 高频超声联合CT用于诊断甲状腺微小乳头状癌淋巴结转移价值分析 [J ] . 中国CT和MRI杂志 , 2021 , 19 ( 12 ): 27 ‑ 29 .
LI H Y , WANG H Y , WENG L X . Diagnostic of high‑frequency ultrasound combined with CT in lymph node metastasis of papillary thyroid micro‑carcinoma [J ] . Chin J CT MRI , 2021 , 19 ( 12 ): 27 ‑ 29 .
季艳会 , 谭建 , 张桂芝 , 等 . 全身广泛骨转移为首发症状的甲状腺微小乳头状癌1例 [J ] . 天津医科大学学报 , 2015 , 21 ( 4 ): 314 ‑ 316 .
JI Y H , TAN J , ZHANG G Z , et al . A case of papillary thyroid carcinoma with extensive bone metastasis as the first symptom [J ] . J Tianjin Med Univ , 2015 , 21 ( 4 ): 314 ‑ 316 .
杨瑞 , 张守鹏 , 黄韬 , 等 . cN0期甲状腺微小乳头状癌淋巴结转移模型的构建和验证以及手术方式探讨 [J ] . 临床耳鼻咽喉头颈外科杂志 , 2021 , 35 ( 2 ): 137 ‑ 140 .
YANG R , ZHANG S P , HUANG T , et al . Construction and verification of lymph node metastasis model of cN0 stage thyroid micropapillary carcinoma and discussion of surgical methods [J ] . J Clin Otorhinolaryngol Head Neck Surg , 2021 , 35 ( 2 ): 137 ‑ 140 .
YU J H , DENG Y H , LIU T T , et al . Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics [J ] . Nat Commun , 2020 , 11 : 4807 .
VAN DIJK S P J , COERTS H I , GUNPUT S T G , et al . Assessment of radiofrequency ablation for papillary microcarcinoma of the thyroid: A systematic review and meta‑analysis [J ] . JAMA Otolaryngol Head Neck Surg , 2022 , 148 ( 4 ): 317 ‑ 325 .
MIYAUCHI A , ITO Y , ODA H . Insights into the management of papillary microcarcinoma of the thyroid [J ] . Thyroid , 2018 , 28 ( 1 ): 23 ‑ 31 .
WELCH H G , DOHERTY G M . Saving thyroids ‑ overtreatment of small papillary cancers [J ] . N Engl J Med , 2018 , 379 ( 4 ): 310 ‑ 312 .
JIN M , KIM H I , HA J , et al . Tumor volume doubling time in active surveillance of papillary thyroid microcarcinoma: A multicenter cohort study in Korea [J ] . Thyroid , 2021 , 31 ( 10 ): 1494 ‑ 1501 .
ZHAO H Q , HUANG T , LI H H . Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer [J ] . Surgery , 2019 , 166 ( 1 ): 55 ‑ 60 .
朱精强 , 雷建勇 . 甲状腺微小乳头状癌过度治疗与不足 [J ] . 中国实用外科杂志 , 2016 , 36 ( 5 ): 520 ‑ 523 .
ZHU J Q , LEI J Y . Over‑treatment and under‑treatment of papillary thyroid microcarcinoma [J ] . Chin J Pract Surg , 2016 , 36 ( 5 ): 520 ‑ 523 .
0
浏览量
8
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621